ConductScience.org, home

Paper41596149

Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine.

Afşin Y and 4 others. Antioxidants (Basel), 2026. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine. Papers, record 41596149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596149

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
4.31, provisional
iCite
Revised in PubMed
2026-01-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Afşin YYaseminhttps://orcid.org/0009-0006-4603-6510
2Alkan Akalın SSenemhttps://orcid.org/0000-0001-8286-2824
3Özdemir İİlhanhttps://orcid.org/0000-0001-9957-0211
4Tuncer MCMehmet Cudihttps://orcid.org/0000-0001-7317-5467
5Öztürk ŞŞamilhttps://orcid.org/0000-0002-9435-8139

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128698459Dietary Natural Products for Prevention and Treatment of Breast Cancer.Nutrients2017https://conductscience.org/library/papers/28698459PubMed
233533291Thymoquinone Potentiated the Anticancer Effect of Cisplatin on Hepatic Tumorigenesis by Modulating Tissue Oxidative Stress and Endoplasmic GRP78/CHOP Signaling.Nutr Cancer2022https://conductscience.org/library/papers/33533291PubMed
339061847The Cancer Antioxidant Regulation System in Therapeutic Resistance.Antioxidants (Basel)2024https://conductscience.org/library/papers/39061847PubMed
432282368Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells.Anticancer Drugs2020https://conductscience.org/library/papers/32282368PubMed
56382953Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.Adv Enzyme Regul1984https://conductscience.org/library/papers/6382953PubMed
620370557Reactive oxygen species in cancer.Free Radic Res2010https://conductscience.org/library/papers/20370557PubMed
740284530Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma.Pharmaceutics2025https://conductscience.org/library/papers/40284530PubMed
833052979Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1.PLoS One2020https://conductscience.org/library/papers/33052979PubMed
936769274Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms.Int J Mol Sci2023https://conductscience.org/library/papers/36769274PubMed
1021376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1132908926Quercetin Downregulates Cyclooxygenase-2 Expression and HIF-1α/VEGF Signaling-Related Angiogenesis in a Mouse Model of Abdominal Aortic Aneurysm.Biomed Res Int2020https://conductscience.org/library/papers/32908926PubMed
1212001989Death and anti-death: tumour resistance to apoptosis.Nat Rev Cancer2002https://conductscience.org/library/papers/12001989PubMed
1321856292The flavonoid quercetin in disease prevention and therapy: facts and fancies.Biochem Pharmacol2012https://conductscience.org/library/papers/21856292PubMed
1433004940Integrated transcriptomic and metabolomic data reveal the flavonoid biosynthesis metabolic pathway in Perilla frutescens (L.) leaves.Sci Rep2020https://conductscience.org/library/papers/33004940PubMed
1537810967Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers.Front Oncol2023https://conductscience.org/library/papers/37810967PubMed
1623076131Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology.Cell Adh Migr2012https://conductscience.org/library/papers/23076131PubMed
1726579469HIF-1α pathway: role, regulation and intervention for cancer therapy.Acta Pharm Sin B2015https://conductscience.org/library/papers/26579469PubMed
1822304911Hypoxia-inducible factors in physiology and medicine.Cell2012https://conductscience.org/library/papers/22304911PubMed
1918655183Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis.J Cell Biochem2008https://conductscience.org/library/papers/18655183PubMed
2030106145PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review).Mol Med Rep2018https://conductscience.org/library/papers/30106145PubMed

See all 27 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42732404
cRGD-Targeted Nanoparticles Co-Loaded with Ag, Quercetin and PD-L1 siRNA with Combined Antibacterial and Immunotherapeutic Functions Against Fusobacterium nucleatum-Associated Triple-Negative Breast Cancer.
Int J Nanomedicine2026https://conductscience.org/library/papers/42732404PubMed
42351676Synergistic Effects of Doxorubicin and Quercetin on ROS-Associated Apoptosis and EGFR/FOXP3 Modulation in OVCAR3 Cells.Biomedicines2026https://conductscience.org/library/papers/42351676PubMed
42255707Pharmacological and Phytochemical Insights Into Ficus benghalensis (Indian Banyan): Anti-Inflammatory, Antioxidant, and Anticancer Potentials.Food Sci Nutr2026https://conductscience.org/library/papers/42255707PubMed
42137366Advancing the frontiers of phytotherapy: a comprehensive review of botanical interventions targeting mitochondrial quality control to ameliorate endometriosis.Front Cell Dev Biol2026https://conductscience.org/library/papers/42137366PubMed
42075801Quercetin Sensitizes Retinoblastoma Cells to Mitomycin C Through Transcriptional Modulation of p53-Regulated Apoptotic Genes: A Preclinical Study.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075801PubMed
42072718Quercetin Enhances Topotecan Cytotoxicity in Retinoblastoma Cells Through ROS-Associated Stress and Apoptotic Signaling.Biomolecules2026https://conductscience.org/library/papers/42072718PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41596149

GET https://conductscience.org/api/papers/v1/41596149/references?page=2